focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.95
Bid: 1.90
Ask: 2.00
Change: -0.05 (-2.50%)
Spread: 0.10 (5.263%)
Open: 1.95
High: 2.00
Low: 1.95
Prev. Close: 1.95
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 up thanks to US economic data

Wed, 03rd Apr 2024 16:54

(Alliance News) - Stock prices in London closed mostly higher on Wednesday, after some data from the US reinforced the interest rate cut trajectory across the Atlantic.

The FTSE 100 index closed up 2.35 points at 7,937.44. The FTSE 250 ended up 39.75 points, 0.2%, at 19,753.64, and the AIM All-Share closed down 0.32 of a point at 742.08.

The Cboe UK 100 ended down 0.1% at 793.01, the Cboe UK 250 closed up 0.1% at 17,166.93, and the Cboe Small Companies ended up 0.7% at 14,656.34.

In European equities on Wednesday, the CAC 40 in Paris ended up 0.4%, while the DAX 40 in Frankfurt ended up 0.5%.

On Wednesday afternoon, there has been some US data for investors to digest.

The US private sector added more jobs in March than a month earlier, numbers from payroll processor ADP showed on Wednesday.

Private sector employment increased by 184,000 jobs in March, rising from 155,000 in February.

February's job growth was ahead of the FXStreet-cited market consensus of 148,000.

Annual wage growth for job-changers rose by 5.1% in March. For job stayers annual wage growth increased by 10%.

"The market is increasingly assuming that a US rate cut is some months away," said Kathleen Brooks, research director at XTB.

"After another strong data report, this time the March ADP private sector payrolls report, the market is increasingly expecting fewer rate cuts from the Fed this year, with the first rate cut currently on a knife edge between July and September."

Meanwhile, a senior bank official said the current strength of the US economy means the Federal Reserve should cut interest rates just once this year, and not until the final quarter.

Atlanta Fed President Raphael Bostic, who is a voting member of the Fed's rate-setting committee this year, told CNBC he now thinks the Fed should make just one cut this year – below the three that were predicted by Fed officials in March.

There was also data on the US service sector.

The seasonally adjusted S&P Global US Services purchasing managers' index edged down to 51.7 in March, a three-month low, from 52.3 in February. Falling closer to the 50-mark separating growth from contraction, it indicates growth decelerated.

Meanwhile, the S&P Global US composite PMI output index fell to 52.1 in March from 52.5 in February.

Separately, the Institute for Supply Management reported that the services PMI edged down to 51.4 in March from 52.6 in February.

"The renewed fall in the ISM services index in March is consistent with the message from the hard data that economic growth is slowing from the unsustainably strong pace in the second half of last year," analysts at Capital Economics said.

Stocks in New York were higher at the London equities close, with the DJIA up 0.2%, the S&P 500 index up 0.4%, and the Nasdaq Composite up 0.6%.

The pound was quoted at USD1.2630 at the London equities close Wednesday, up compared to USD1.2564 at the close on Tuesday. The euro stood at USD1.0827 at the European equities close Wednesday, higher against USD1.0771 at the same time on Tuesday. Against the yen, the dollar was trading at JPY151.72, up compared to JPY151.60 late Tuesday.

In London's FTSE 100, Prudential lost 2.7% to 720.40 pence, after Barclays cut the insurer's price target to 1,390p per share from 1,640p, while Barclays rates the stock at 'overweight'.

In the FTSE 250, International Distributions Services rose 4.3%.

IDS unit Royal Mail proposed a change to its UK letter delivery offering, as it grapples with weaker volumes, in a move which could see "fewer than 1,000 voluntary redundancies".

The measures could trim the net cost of the UK postal universal service operation by GBP300 million per year.

"This is very dependent on how quickly reform is enacted and the rate of letter decline. These savings would allow Royal Mail to continue to invest in the modernisation and transformation of the business to provide products and services that customers want and reduce its environmental impact," IDS said.

On AIM, Genedrive shares surged 39%.

The molecular diagnostics company announced that the UK's National Institute for Health & Care Excellence has recommended in draft guidance that Genedrive's CYP2C19-ID test should be used as the point-of-care test of choice for ischemic stroke and transient ischaemic attack patients.

Brent oil was quoted at USD89.69 a barrel at the London equities close Wednesday, up from USD88.11 late Tuesday.

Gold was quoted at USD2,286.90 an ounce at the London equities close Wednesday, up against USD2,266.55 at the close on Tuesday.

In Thursday's UK corporate calendar, there are full year results from LungLife AI.

The economic calendar for Thursday has a producer price reading from the eurozone at 1000 BST.

There is also a slew of composite PMI data from the eurozone, Germany, and the UK.

Across the Atlantic, there is the weekly initial jobless claims from the US.

Meanwhile, financial markets will be closed in Hong Kong and Shanghai will be closed for Tomb Sweeping Day.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
10 May 2024 12:10

IN BRIEF: Genedrive completes placing portion of GBP6 million raise

Genedrive PLC - Manchester-based pharmacogenetic testing - Completes placing of 138.8 million new shares at 1.5 pence each, raising GBP2.1 million. The placing is part of an overall equity raise being run by Peel Hunt LLP. Late Thursday, Genedrive had said it will try to raise a minimum of GBP6.0 million, including offers to retail investors. If that minimum is not reached, then only the firm placing will go ahead. The placing and retail offer prices will be the same and represent a more than 50% discount to Genedrive's closing price on Thursday. The placing shares will almost double Genedrive's total, and the retail offers could see another 376.4 million new shares issued. It expects to call a general meeting for May 31 to approve the share issue.

Read more
10 May 2024 10:59

AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
10 May 2024 07:00

IN BRIEF: Genedrive aims to raise at least GBP6 million in share offer

Genedrive PLC - Manchester-based pharmacogenetic testing company - Seeks to raise a minimum of GBP6.0 million from an offer of new shares at 1.5 pence each. The announcement is made after the London market close on Thursday, and the price represents a more than 50% discount to Genedrive's closing price. The equity raise will be split into a firm placing of shares for GBP2.5 million, an offer to new and existing retail investors via the REX platform for GBP3.5 million, and an open offer to existing shareholders for GBP2.1 million. Genedrive says that if the GBP6.0 million minimum target is not reached, then only the firm placing will go ahead. The share sale is being run by broker Peel Hunt LLP.

Read more
24 Apr 2024 17:26

Genedrive enters clinical trial deal in US for MT-RNR1 US approval

(Alliance News) - Genedrive PLC on Wednesday said it has entered into a clinical trial agreement to support clinical studies to progress the regulatory approval of its MT-RNR1 product.

Read more
3 Apr 2024 13:54

Genedrive shares jump on NICE test recommendation

(Sharecast News) - Genedrive shares were surging on Wednesday, after it received a significant endorsement from the UK's National Institute for Health and Care Excellence (NICE) regarding its 'CYP2C19-ID' test.

Read more
3 Apr 2024 11:49

Genedrive shares surge as UK's NICE backs test for ischaemic stroke

(Alliance News) - Genedrive PLC on Wednesday praised the National Health Service's work on strokes and mini strokes as a test by the company received a recommendation from the UK's National Institute for Health & Care Excellence.

Read more
3 Apr 2024 10:47

AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
28 Mar 2024 14:35

EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
15 Mar 2024 14:27

Genedrive receives R&D tax credit, plans fundraise

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive announced the receipt of a research and development tax credit totalling £0.8m on Friday, taking its unaudited cash balances to £1.2m.

Read more
15 Mar 2024 13:50

Genedrive down as plans equity raise despite GBP800,000 tax credit

(Alliance News) - Genedrive PLC shares fell on Friday, after it said it has received a GBP800,000 research and development tax credit.

Read more
19 Feb 2024 18:57

TRADING UPDATES: Coro seals sale terms, Powerhouse makes good progress

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
19 Feb 2024 10:56

Genedrive set to apply for NICE EVA funding

(Sharecast News) - Genedrive shares rose on Monday, on the launch of the NICE early value assessment (EVA) evidence generation funding call, backed by the National Institute for Health and Care Research (NIHR).

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more
2 Jan 2024 14:39

Genedrive confirms £0.6m equity prepayment drawdown

(Sharecast News) - Genedrive confirmed a planned £0.6m drawdown as part of its £5m equity prepayment facility on Tuesday, which it initially disclosed on 31 March 2023.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.